What is the history of Pemphigus?

TL;DR: Pemphigus is a group of rare, life-threatening autoimmune blistering diseases that was first formally described in the 17th century, though its mechanism remained a mystery for hundreds of years. Today, we understand pemphigus as a condition where the body’s immune system attacks the "glue" holding skin cells together, a discovery that revolutionized treatment from ineffective salves to life-saving immunosuppressive therapies.

When was Pemphigus first recognized in medical literature?

The term pemphigus originates from the Greek word "pemphix," meaning bubble or blister. While descriptions of blistering skin conditions appear in ancient texts, the term was formally introduced into medical literature in the late 17th century. In 1694, the physician Hippocrates-like observer Lazare Rivière provided one of the earliest clinical descriptions, though early physicians often conflated pemphigus with other infectious or syphilitic skin conditions, leading to centuries of confusion regarding its true nature.

How did our understanding of Pemphigus evolve?

For centuries, pemphigus was considered a contagious or "miasmatic" disease. It wasn't until the mid-20th century that the true pathology was unveiled. A major milestone occurred in 1964, when researchers Beutner and Jordon utilized immunofluorescence to identify circulating autoantibodies in the blood of patients with pemphigus. This pivotal discovery proved that the disease was not an infection, but an autoimmune disorder where the body produces antibodies (specifically anti-desmoglein) that attack desmosomes—the structures that act as cellular "glue" to keep skin cells joined together.

What were the major milestones in treatment development?

Before the mid-20th century, a diagnosis of pemphigus was often fatal, as there were no effective treatments. The history of managing pemphigus is marked by several critical advancements:

• The Steroid Era (1950s): The introduction of systemic corticosteroids transformed pemphigus from a near-certain terminal diagnosis into a manageable chronic condition.


• Immunosuppressive Agents (1970s-80s): The addition of drugs like azathioprine, mycophenolate mofetil, and cyclophosphamide allowed clinicians to lower steroid doses, reducing long-term side effects.


• Biologic Therapies (2000s-Present): The approval of Rituximab, a monoclonal antibody that depletes B-cells, has become a gold-standard treatment, offering many patients long-term remission.

How has modern technology changed our understanding?

Modern genetics and molecular biology have refined our understanding of pemphigus beyond simple clinical observation. We now know that specific human leukocyte antigen (HLA) genes significantly influence individual susceptibility to developing the disease. Furthermore, the development of high-sensitivity ELISA tests allows physicians to measure anti-desmoglein antibody levels in real-time, helping to predict disease flares and guide treatment adjustments with unprecedented precision.

How has patient advocacy shaped the journey?

Historically, patients with pemphigus faced significant isolation due to the visible, often painful nature of the skin lesions. The evolution of patient advocacy, including the growth of global communities like DiseaseMaps.org—where 199 members currently share their experiences—has been instrumental in shifting the focus from purely clinical outcomes to the "patient-reported experience." Advocacy groups have successfully pushed for faster diagnostic pathways and increased funding for clinical trials, ensuring that the patient voice is integrated into research priorities.

Next steps

• Consult a board-certified dermatologist who specializes in autoimmune blistering diseases.


• Connect with the 199 members of the DiseaseMaps.org pemphigus community to share experiences and coping strategies.


• Ask your specialist about current clinical trials if standard immunosuppressive therapies are not providing adequate control.


• Monitor for early warning signs of flares, such as new oral erosions or small blisters, and report them to your care team immediately.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Pemphigus.


• Orphanet: Pemphigus group.


• OMIM (Online Mendelian Inheritance in Man): Entry for Pemphigus Vulgaris.


• International Pemphigus & Pemphigoid Foundation (IPPF).